Sonoma Pharmaceuticals, Inc.·4

Jan 14, 8:34 PM ET

Weigerstorfer Philippe 4

4 · Sonoma Pharmaceuticals, Inc. · Filed Jan 14, 2022

Insider Transaction Report

Form 4
Period: 2022-01-14
Transactions
  • Award

    Stock option (right to buy)

    2022-01-14+30,00030,000 total
    Exercise: $4.60Exp: 2032-01-14Common stock (30,000 underlying)
Footnotes (2)
  • [F1]The options vest 10,000 each on 07/14/2022, 07/14/2023 and 07/14/2024, or upon change of control.
  • [F2]The options were awarded and granted to Mr. Weigerstorfer for services performed on the Board of Directors.

Documents

1 file
  • 4
    ownership.xmlPrimary